Live Quote · NASDAQCGEMHealthcare· Medical - Pharmaceuticals

Cullinan Therapeutics, Inc.

$17.63 2.03%(+$0.35)
TickerSpark Score
60/100
Mixed
80
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGEM research report →

52-Week Range87% of range
Low
$5.68
Current
$17.63
High
$19.43
Company Overviewcullinantherapeutics.com

About the company

Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively advancing its therapeutic candidates through clinical trials. This company is focused on developing innovative treatments primarily for cancer, including those that leverage the immune system (immuno-oncology).

CEO
Nadim Ahmed
IPO
2021
Employees
111
HQ
Cambridge, MA, US

Price Chart

+127.19% · this period
$18.48$12.12$5.75Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.08B
P/E
-4.70
P/S
0.00
P/B
2.85
EV/EBITDA
-4.58
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-51.45%
ROIC
-65.21%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-219,879,000 · -31.36%
EPS
$-3.72 · -19.61%
Op Income
$-241,648,000
FCF YoY
-20.99%
Performance & Tape
52W High
$19.43
52W Low
$5.68
50D MA
$15.01
200D MA
$11.92
Beta
0.01
Avg Volume
1.08M

Get TickerSpark's AI analysis on CGEM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26SUMER JACQUELYN Lother2,470
Jun 30, 26Fenton Mary Kayother1,541
Jun 16, 26Rosenberg Anthonyother25,319
Jun 16, 26Meek David D.other25,319
Jun 16, 26Webster Stephen Wother25,319
Jun 16, 26Allen Andrew Rother21,781
Jun 16, 26Thistle Maryother25,319
Jun 16, 26Doyle Mittieother21,781
May 5, 26Michaelson Jenniferother4,000
May 5, 26Michaelson Jennifersell7,800
Coverage · CGEM

Our CGEM coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on CGEM yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate CGEM report →
Internal Compare

Similar companies

Peers in the same neighborhood.